Agency Links:    Home   Contact Us    Compliments & Complaints   Help    Site Map
Link to Homepage

Patient/Public Info  |  Regional Services  |  Health Professionals Info  |  About BCCA  |  Research  |  Donating

Gynecology

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use available at www.bccancer.bc.ca/legal.htm.

Please note: All links in the tables below open PDF documents.

Ovarian Treatments
Protocol Code and Description Available documents
(revision date indicated in red)
GOBEP: Therapy of non-dysgerminomatous ovarian germ cell cancer using Bleomycin, Etoposide and CISplatin - Protocol (01 Aug 2014)
- Preprinted Order (01 Aug 2014)
Patient handout (01 Feb 2011)
GOEP: Therapy of Dysgerminomatous Ovarian Germ Cell Cancer Using CISplatin and Etoposide - Protocol (01 Aug 2014)
- Preprinted Order (01 Aug 2014)
GOOVAI: Therapy for Advanced Ovarian Cancer using an Aromatase Inhibitor Protocol (01 Jan 2012)
Preprinted Order (01 Jan 2012)
GOOVCADM: Primary Treatment of Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer, with no Visible Residual Tumour (Moderate-High Risk) Using CARBOplatin and DOCEtaxel - Protocol (01 Aug 2014)
- Preprinted order (01 Aug 2014)
GOOVCADR: Second Line Treatment Using DOCEtaxel and CARBOplatin for Epithelial Ovarian Cancer Relapsing after Primary Treatment - Protocol (01 Aug 2014)
- Preprinted order (01 Aug 2014)
GOOVCADX: Primary Treatment of Visible Residual (Extreme Risk) Invasive Epithelial Ovarian Cancer Using CARBOplatin and DOCEtaxel - Protocol (01 Aug 2014)
- Preprinted order (01 Aug 2014)
GOOVCAG: Treatment of Advanced Ovarian Cancer in Patients Who Have Progressed or Recurred Following First-line Platinum-based Treatment Using CARBOplatin and Gemcitabine Protocol (01 Jun 2013)
Preprinted order (01 Apr 2014)
GOOVCARB: First or Second Line Therapy for Invasive Epithelial Ovarian Cancer using Single-Agent CARBOplatin - Protocol (01 Feb 2014)
- Preprinted order (01 Jun 2013)
GOOVCATM: Primary treatment of invasive epithelial ovarian, fallopian tube and primary peritoneal cancer, with no visible residual tumour (moderate-high risk) using CARBOplatin and PACLitaxel - Protocol (01 Aug 2014)
- Preprinted order (01 Aug 2014)
Patient Handout (04 Jul 2011)
GOOVCATR: Second line treatment using PACLitaxel and CARBOplatin for epithelial ovarian cancer relapsing after primary treatment - Protocol (01 Aug 2014)
- Preprinted order (01 Aug 2014)
Patient Handout (04 Jul 2011)
GOOVCATX: Primary treatment of visible residual (extreme risk) invasive epithelial ovarian cancer in ambulatory care settings using PACLitaxel and CARBOplatin - Protocol (01 Aug 2014)
- Preprinted order (01 Aug 2014)
Patient Handout (01 Apr 2013)
GOOVCIS: Therapy for Invasive Epithelial Ovarian Cancer using CISplatin Protocol (01 Apr 2013)
- Preprinted order (27 Jun 2011)
-
 Patient handout (01 Mar 2010)
GOOVDDCAT: Treatment Of Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using CARBOplatin and Weekly PACLitaxel Protocol (01 Aug 2014)
Preprinted order (01 Aug 2014)
Patient handout (01 Sep 2013)
GOOVDOC: Treatment Of Progressive, Platinum-Refractory Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma Or Fallopian Tube Carcinoma Using DOCEtaxel - Protocol (01 Sep 2014)
- Preprinted order (01 Aug 2014)
GOOVETO: Treatment of Relapsed/Progressing Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using Etoposide - Protocol (01 Sep 2014)
- Preprinted order (01 Aug 2014)
GOOVGEM: Palliative chemotherapy for re-treatment of ovarian, tubal, and peritoneal cancer using gemcitabine - Protocol (01 Sep 2014)
- Preprinted order (01 Nov 2012)
GOOVIPPC: BCCA Protocol Summary for Primary Treatment of Stage III less than or equal to 1 cm Visible Residual Invasive Epithelial Ovarian Cancer or Stage 1 Grade 3 or Stage II Grade 3 Papillary Serous Ovarian Cancer Using Intravenous and Intraperitoneal PACLitaxel and Intraperitoneal CARBOplatin - Protocol (01 Aug 2014)
- Preprinted order (01 Aug 2014)
- Patient handout (01 Oct 2007)
GOOVLDOX: Treatment of Relapsed/Progressing, Epithelial Ovarian, Primary Peritoneal Or Fallopian Tube Carcinoma Using Pegylated Liposomal DOXOrubicin - Protocol (01 Sep 2014)
- Preprinted order (01 Jul 2013)
- Patient handout (01 Aug 2007)
GOOVPLDC: Second line treatment for Epithelial Ovarian Cancer Relapsing after primary treatment using Pegylated Liposomal DOXOrubicin (PLD) and CARBOplatin Protocol (01 Aug 2013)
Preprinted order (01 Jul 2013)
Patient Handout (01 Sep 2014)
GOOVTAM: Therapy for Advanced Ovarian Cancer Using Tamoxifen Protocol (1 Mar 2013)
Preprinted order (1 Mar 2013)
GOOVTAX3: Treatment of progressive, platinum-refractory epithelial ovarian carcinoma, primary peritoneal carcinoma or fallopian tube carcinoma using PACLitaxel - Protocol (01 Sep 2014)
- Preprinted order (01 Aug 2014)
GOOVTOP: Treatment of relapsed/progressive epithelial ovarian, fallopian tube or primary peritoneal cancer using Topotecan - Protocol (01 Sep 2014)
- Preprinted order (01 Oct 2014)
GOOVVIN: Palliative Chemotherapy for Re-treatment of Ovarian, Tubal, and Peritoneal Cancer Using Vinorelbine - Protocol (01 Sep 2014)
- Preprinted order (01 Jul 2014)

 

Cervical Treatments
Protocol Code and Description Available Documents
(revision date indicated in red)
GOCXAJCAT: Primary Adjuvant Treatment of Adenocarcinoma/Adenosquamous Cancer of the Cervix with CARBOplatin and PACLitaxel Prior to Irradiation with or without CISplatin Protocol (01 Aug 2014)
Preprinted order (01 Aug 2014)
GOCXCAD: Treatment of Advanced/Recurrent Non-Small Cell Cancer of the Cervix with CARBOplatin and DOCEtaxel in Ambulatory Care Settings - Protocol (01 Aug 2014)
- Preprinted order (01 Aug 2014)
GOCXCAT: Primary Treatment of Advanced/Recurrent Non-Small Cell Cancer of the Cervix with CARBOplatin and PACLitaxel in Ambulatory Care Settings - Protocol (01 Aug 2014)
- Preprinted order (01 Aug 2014)
UGOCXCATB: Primary Treatment of Metastatic or Recurrent Squamous Cancer of the Cervix with Bevacizumab, CARBOplatin and PACLitaxel Protocol (01 Aug 2014)
Preprinted order (01 Aug  2014)
Patient Handout (01 Apr 2014)
GOCXCRT: Treatment of High Risk Squamous Carcinoma, Adenocarcinoma, or Adenosquamous Carcinoma of the Cervix with Concurrent CISplatin and Radiation - Protocol (01 Jun 2014)
- Preprinted order (01 Nov  2014)
Patient Handout (01 Dec 2012)

Back to top

Endometrial Treatments
Protocol Code and Description Available documents
(revision date indicated in red
GOENDAI: Advanced Therapy for Endometrial Cancer using an Aromatase Inhibitor Protocol (01 Apr 2010)
- Preprinted order (01 Sep 2010)
GOENDCAD: Treatment of Primary Advanced or Recurrent Endometrial Cancer using CARBOplatin and DOCEtaxel - Protocol (01 Aug 2014)
- Preprinted order (01 Aug 2014)
GOENDCAT: Treatment of Primary Advanced or Recurrent Endometrial Cancer using CARBOplatin and PACLitaxel - Protocol (01 Aug 2014)
- Preprinted order (01 Aug 2014)
Patient Handout (04 July 2011)
GOENDH: Non-Aromatase Inhibitor Hormonal Treatment of Endometrial Cancer Protocol (01 Jan 2013)
Preprinted order (01 Nov 2014)

Back to top

Others
Protocol Code and Description Available documents
(revision date indicated in red
GOSADG: Treatment of Uterine Sarcoma Cancer using DOCEtaxel and Gemcitabine Protocol (01 Aug 2014)
- Preprinted order (01 Aug 2014)
GOSMCCRT: Treatment of Small Cell or Neuroendocrine Carcinoma of Gynecologic System Origin using PACLitaxel, CISplatin, Etoposide and CARBOplatin with Radiation

Protocol (01 Aug 2014)
- GOSMCCRT(c) Preprinted order (01 Jun 2013)
GOSMCCRT(d) Preprinted order (01 Aug 2014)
GOSMCCRT(e) Preprinted order (01 Jun 2013)
UGOTDHR: Therapy for high risk gestational trophoblastic (GO9103) "MACE" using CISplatin, Etoposide, Dactinomycin, Methotrexate and Leucovorin - Protocol (01 May 2013)
GOTDLR: Therapy for low risk gestational trophoblastic neoplasia (GO 94 02) using Methotrexate, Leucovorin and Actinomycin D - Protocol (01 Feb 2013)

Back to top